Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Releases Inaugural Business Update Video

GlobeNewswire September 10, 2019

Kane Biotech Announces Second Quarter 2019 Financial Results

GlobeNewswire August 21, 2019

Kane Biotech Announces Q2 Earnings Release and Inaugural Business Update Video

GlobeNewswire August 14, 2019

Kane Biotech Announces Share Purchase by CEO, Exercise of Warrants, Reimbursement of Insider Advances and Extension of Loan

GlobeNewswire August 13, 2019

Kane Biotech Strengthens Team with New Additions in Animal Health and Quality Assurance

GlobeNewswire August 12, 2019

IIROC Trading Resumption - KNE

Canada NewsWire August 6, 2019

Kane Biotech Awarded $3.8 Million in Non-Dilutive Government Funding

GlobeNewswire August 6, 2019

IIROC Trading Halt - KNE

Canada NewsWire August 6, 2019

Kane Biotech Announces New Funding Granted from CanExport Program

GlobeNewswire August 1, 2019

Kane Biotech Announces Exclusive Distribution Agreement with Eetoys Pet Products Limited

GlobeNewswire July 18, 2019

Kane Biotech Announces New Agreement with FreeMind Group

GlobeNewswire July 16, 2019

Kane Biotech Secures Large Order from Leading Quebec Retailer

GlobeNewswire June 25, 2019

IIROC Trading Resumption - KNE

Canada NewsWire June 20, 2019

Kane Biotech and Nestlé Reach Settlement

GlobeNewswire June 20, 2019

IIROC Trading Halt - KNE

Canada NewsWire June 20, 2019

Kane Biotech to Showcase Technologies and Products at the 2019 BIO International Convention

GlobeNewswire May 29, 2019

Kane Biotech Announces First Quarter 2019 Financial Results, Extension of Loan and Insider Funding

GlobeNewswire May 22, 2019

Kane Biotech Announces First Quarter 2019 Earnings Conference Call and Business Update

GlobeNewswire May 16, 2019

Kane Biotech Provides Update on Exclusive License and Distribution Agreement with Dechra Veterinary Products

GlobeNewswire April 30, 2019

Kane Biotech Announces New Sales Representation by SLA Brands

GlobeNewswire April 24, 2019